• Profile
Close

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH)

Journal of Viral Hepatitis Oct 11, 2017

Nordmann S, et al. - Researchers here assessed whether cannabis use in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infected patients was associated with a reduced risk of steatosis, measured by ultrasound examination. Findings suggested daily cannabis use as a protective factor against steatosis in HIV-HCV co-infected patients. Findings thus support the necessity for a clinical evaluation of cannabis-based pharmacotherapies in this population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay